Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  04/15/2008
 
Trade Name:  Patanase Nasal Spray
 
Generic or Proper Name (*):  olopatadine hydrochloride
 
Indications Studied:  Relief of symptoms of seasonal allergic rhinitis (SAR) in patients 12 years of age and older
 
Therapeutic Category:  Antihistamine
 
Ages Studied:  12 years and older
 
Study #:  8
 
Study Type:  Efficacy/Safety/Pharmacokinetic
 
Study Design:  Single-Blind/Parallel Group/Traditional Pharmacokinetic
 
No Patients:  271
 
No Centers:  7
 
No Countries:  1
 
BPCA(B), PREA(P):  P
 
-
-